Endurant Capital Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Hold
2021
Q3
Sell
2021
Q2
$5.83M Buy
2021
Q1
$5.14M Sell
2020
Q4
$9.65M Buy
2020
Q3
$5.29M Sell
2020
Q2
$5.48M Buy
2020
Q1
$1.93M Buy
2016
Q4
Sell
2016
Q3
$361K Sell
2016
Q2
$245K Buy
2016
Q1
$116K Hold
2015
Q4
$158K Buy